196 related articles for article (PubMed ID: 12399513)
1. Challenges in oral therapy for erectile dysfunction.
Seftel AD
J Androl; 2002; 23(6):729-36. PubMed ID: 12399513
[No Abstract] [Full Text] [Related]
2. [Erectile dysfunction].
Lyngdorf P
Ugeskr Laeger; 2002 Oct; 164(41):4779-83. PubMed ID: 12407881
[No Abstract] [Full Text] [Related]
3. Oral and topical treatment of erectile dysfunction. Present and future.
Morales A; Heaton JP; Johnston B; Adams M
Urol Clin North Am; 1995 Nov; 22(4):879-86. PubMed ID: 7483136
[TBL] [Abstract][Full Text] [Related]
4. [Conservative treatment of erectile dysfunction].
Papp G; Erdei E
Orv Hetil; 2003 Jun; 144(22):1061-6. PubMed ID: 12847815
[TBL] [Abstract][Full Text] [Related]
5. Commentary on apomorphine versus sildenafil for erectile dysfunction.
Carson CC
J Urol; 2008 May; 179(5 Suppl):S95-6. PubMed ID: 18405768
[No Abstract] [Full Text] [Related]
6. Future directions in erectile dysfunction therapy.
Mulhall JP
Postgrad Med; 2000 May; 107(6 Suppl Educational):19-23. PubMed ID: 19667519
[TBL] [Abstract][Full Text] [Related]
7. [Treatment per os of disorders of erection].
Giuliano F
Prog Urol; 1997 Feb; 7(1):108-9. PubMed ID: 9116726
[No Abstract] [Full Text] [Related]
8. New oral agents for erectile dysfunction: what is changing in our practice?
Aversa A; Fabbri A
Asian J Androl; 2001 Sep; 3(3):175-9. PubMed ID: 11561186
[TBL] [Abstract][Full Text] [Related]
9. Newer phosphodiesterase inhibitors: comparison with established agents.
McNamara ER; Donatucci CF
Urol Clin North Am; 2011 May; 38(2):155-63. PubMed ID: 21621082
[TBL] [Abstract][Full Text] [Related]
10. [Apomorphine and erectile dysfunction].
Tan DQ; Yao Y; Zhang J
Zhonghua Nan Ke Xue; 2007 Sep; 13(9):818-21. PubMed ID: 17929561
[TBL] [Abstract][Full Text] [Related]
11. [Phosphodiesterase 5 inhibition in erectile dysfunction. Long-term administration without therapeutic advantage].
MMW Fortschr Med; 2009 Jan; 151(1-2):50-1. PubMed ID: 19227645
[No Abstract] [Full Text] [Related]
12. [Intracavernous injections: role in the diagnosis and therapy of problems in erection].
Jardin A; Benoit G; Giuliano F
Journ Annu Diabetol Hotel Dieu; 1993; ():359-74. PubMed ID: 8101244
[No Abstract] [Full Text] [Related]
13. [Current role of intracavernous therapy in the treatment of erectile dysfunction].
Asuar Aydillo S
Arch Esp Urol; 2002 Jun; 55(5):475-82. PubMed ID: 12174413
[No Abstract] [Full Text] [Related]
14. DA-8159 has erectile potentials much longer than the plasma half-life in a conscious rabbit model.
Kang KK; Ahn GJ; Shim HJ; Kwon JW
Life Sci; 2004 Jul; 75(9):1075-83. PubMed ID: 15207655
[TBL] [Abstract][Full Text] [Related]
15. Erection, erectile dysfunction: what has heart got to do with it?
Khandheria BK
Herz; 2003 Jun; 28(4):275-6. PubMed ID: 12916517
[No Abstract] [Full Text] [Related]
16. [Therapeutic efficacy of a course administration of vardenafil--inhibitor of phosphodiesterase-5--in erectile dysfunction].
Aliaev IuG; Vinarov AZ; Akhvlediani ND
Urologiia; 2007; (1):45-6, 49. PubMed ID: 17471999
[TBL] [Abstract][Full Text] [Related]
17. Pharmacologic treatment of impotence.
Malloy TR; Malkowicz B
Urol Clin North Am; 1987 May; 14(2):297-305. PubMed ID: 2883750
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of sildenafil citrate (Viagra) and tadalafil (Cialis) on sexual responses in Saudi men with erectile dysfunction in routine clinical practice.
Ali ST
Pak J Pharm Sci; 2008 Jul; 21(3):275-81. PubMed ID: 18614424
[TBL] [Abstract][Full Text] [Related]
19. Update on oral treatments for male erectile dysfunction.
Kalsi JS; Kell PD
J Eur Acad Dermatol Venereol; 2004 May; 18(3):267-74. PubMed ID: 15096134
[TBL] [Abstract][Full Text] [Related]
20. Commentary on adjunctive use of testosterone gel with sildenafil for erectile dysfunction.
Morales A
J Urol; 2008 May; 179(5 Suppl):S103. PubMed ID: 18405738
[No Abstract] [Full Text] [Related]
[Next] [New Search]
